| Indicators | Browse All

Scilex Holding Company (SCLX)

Healthcare | Drug Manufacturers - General | Palo Alto, United States | NasdaqCM
8.76 USD -0.68 (-7.203%) ⇩ (July 14, 2026, 4 p.m. EDT)

Short-term:★★⯪☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 6:22 a.m. EDT

The immediate outlook is clouded by severe structural damage rather than temporary weakness. The company has endured a catastrophic four-year collapse, losing over 98% of its value, with the last three consecutive years showing double-digit declines culminating in a 90% drop last year. This sustained trajectory indicates a business model that has fundamentally broken down, rendering any current recovery attempts highly speculative. While recent headlines celebrate a $100 million strategic investment and a term sheet for a quantum computing venture, these are desperate liquidity injections for a company with negative book value, massive debt loads exceeding ten times its cash reserves, and a current ratio of 0.084 signaling imminent solvency risks. The operational reality is stark: the company is burning cash, with operating cash flow in the negative millions despite reporting positive free cash flow, likely due to aggressive accounting or one-time adjustments masking a deteriorating core. There is no dividend to provide a floor, and the balance sheet is a fortress of liabilities. Even with the latest capital infusion, the path to profitability remains obscured by years of eroding margins and shrinking revenues. For investors, this represents a high-risk gamble on a turnaround story that has already failed for nearly half a decade, rather than a sound investment opportunity.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.278175
AutoETS0.278212
AutoARIMA0.278595
MSTL0.279607

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 28%
H-stat 5.11
Ljung-Box p 0.000
Jarque-Bera p 0.135
Excess Kurtosis -1.33
Attribute Value
Sector Healthcare
Revenue per Share 3.432
Market Cap 61,609,124
Forward P/E 12.00
Beta 1.73
Website https://www.scilexholding.com

Info Dump

Attribute Value
52 Week Change 1.2526956
Address1 960 San Antonio Road
All Time High 368.30637
All Time Low 2.241594
Ask 11.22
Ask Size 2
Average Daily Volume10 Day 327,580
Average Daily Volume3 Month 177,142
Average Volume 177,142
Average Volume10Days 327,580
Beta 1.727
Bid 6.83
Bid Size 2
Book Value -35.436
City Palo Alto
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 8.76
Current Ratio 0.084
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 9.7399
Day Low 8.64
Display Name Scilex Holding
Earnings Timestamp End 1,773,349,200
Earnings Timestamp Start 1,773,349,200
Ebitda -270,086,016
Ebitda Margins 0.0
Enterprise To Ebitda -0.592
Enterprise To Revenue 4.718
Enterprise Value 159,756,112
Eps Forward 0.73
Eps Trailing Twelve Months -40.5
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 5.8936343
Fifty Day Average Change 2.866366
Fifty Day Average Change Percent 0.48634946
Fifty Two Week Change Percent 125.269554
Fifty Two Week High 21.33873
Fifty Two Week High Change -12.57873
Fifty Two Week High Change Percent -0.58947885
Fifty Two Week Low 2.615193
Fifty Two Week Low Change 6.1448073
Fifty Two Week Low Change Percent 2.3496573
Fifty Two Week Range 2.615193 - 21.33873
Financial Currency USD
First Trade Date Milliseconds 1,614,954,600,000
Float Shares 5,686,535
Forward Eps 0.73
Forward P E 12.0
Free Cashflow 5,986,500
Full Exchange Name NasdaqCM
Full Time Employees 34
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.59654
Gross Profits 20,200,000
Has Pre Post Market Data 1
Held Percent Insiders 0.11667
Held Percent Institutions 0.13104
Implied Shares Outstanding 7,033,005
Industry Drug Manufacturers - General
Industry Disp Drug Manufacturers - General
Industry Key drug-manufacturers-general
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,781,568,000
Last Split Factor 1,606:1000
Long Business Summary Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company also develops three product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel - SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4%, a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules), a novel low-dose delayed-release naltrexone hydrochloride, which has completed phase 1 trials for the treatment of fibromyalgia. It has an agreement with Oishi and Itochu to develop lidocaine tape products, including ZTlido and SP-103; Lifecore Biomedical, LLC for clinical trial material manufacturing and development services for SEMDEXA; and Tulex Master, which develops, tests, and manufactures clinical supplies of SP-104. Scilex Holding Company is based in Palo Alto, California.
Long Name Scilex Holding Company
Market us_market
Market Cap 61,609,124
Market State PRE
Max Age 86,400
Message Board Id finmb_607715156
Most Recent Quarter 1,774,915,200
Net Income To Common -419,676,992
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 66,391,557
Open 9.25
Operating Cashflow -3,298,000
Operating Margins -3.7349398
Payout Ratio 0.0
Phone 650 516 4310
Previous Close 9.440001
Price Hint 2
Price To Book -0.24720623
Price To Sales Trailing12 Months 1.8194177
Profit Margins 0.0
Quick Ratio 0.066
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.6800003
Regular Market Change Percent -7.2033925
Regular Market Day High 9.7399
Regular Market Day Low 8.64
Regular Market Day Range 8.64 - 9.7399
Regular Market Open 9.25
Regular Market Previous Close 9.440001
Regular Market Price 8.76
Regular Market Time 1,784,059,200
Regular Market Volume 78,251
Return On Assets -0.92783
Revenue Growth 0.721
Revenue Per Share 3.432
Sand P52 Week Change 0.20365608
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 7,033,004
Shares Percent Shares Out 0.0233
Shares Short 163,989
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 229,014
Short Name Scilex Holding Company
Short Percent Of Float 0.0296
Short Ratio 1.96
Source Interval 15
State CA
Symbol SCLX
Total Cash 3,361,000
Total Cash Per Share 0.478
Total Debt 106,359,000
Total Revenue 33,862,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -40.5
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 7.4266467
Two Hundred Day Average Change 1.3333535
Two Hundred Day Average Change Percent 0.17953642
Type Disp Equity
Volume 78,251
Website https://www.scilexholding.com
Zip 94,303